Preliminary consultancy, project definition and management.




    • OEL/OEB/ASL Assessment including engineering support for containment measures.


    • PDE Assessment for Medicinal Products/Active Ingredients in shared facilities (EMA/CHMP/SWP/169430/2012/00).


    • ERA for Medicinal Products for human use, as for EMEA/CHMP/SWP/4447/00, or Veterinary Use, as for VICH GL6 and VICH GL38.


    • E&L (Extractables and Leachables) on finished pharma products.


    • Impurity Safety Assessment (ICH Q3A, ICH Q3B and ICH M7), Genotoxicity, Toxicity and Risk Assessment.


    • Elemental impurities evaluation (ICH Q3D), Genotoxicity, Toxicity and Risk Assessment in Medicinal Products for human use or veterinary use.


    • Solvents evaluation (ICH Q3C), gentoxicity, toxicity and Risk Assessment.


    • “In silico” prediction for Toxicology (DEREK Nexus), Genotoxicity (SARAH Nexus), Metabolism (METEOR Nexus) and Degradation Products (ZENETH Nexus); interpretation of results and Expert Report by our ERT® (European Registered Toxicologist).